Table 2.
Effect of treatment with Cyclophosphamide or abnormal Savda Munziq traditional Uyghur Medicine in Mice Transplanted with S180 Tumour on total body and organ weights (mean ± SD)
| Group | Dosage (g/kg) | Tumour weight (g) | Thymus weight (g) | Spleen weight (g) | Liver weight (g) | Body weight (g) |
|---|---|---|---|---|---|---|
| Control |
0 |
0.00 ± 0.00 |
0.10 ± 0.01 |
0.09 ± 0.01 |
1.21 ± 0.05 |
30.40 ± 1.44 |
| Model |
0 |
0.60 ± 0.03 |
0.09 ± 0.02 |
0.12 ± 0.01 |
1.30 ± 0.07 |
32.57 ± 1.50 |
| CY |
0.02 |
0.29 ± 0.01* |
0.07 ± 0.01 |
0.08 ± 0.01 |
1.15 ± 0.05 |
25.96 ± 1.32 |
| ASMq low |
2 |
0.34 ± 0.02*# |
0.10 ± 0.01# |
0.11 ± 0.01*# |
1.35 ± 0.13*# |
27.34 ± 1.26*# |
| ASMq medium |
4 |
0.21 ± 0.18*# |
0.09 ± 0.01*# |
0.12 ± 0.02*# |
1.35 ± 0.37 |
29.82 ± 2.24# |
| ASMq high | 8 | 0.30 ± 0.53* | 0.11 ± 0.14# | 0.11 ± 0.11*# | 1.23 ± 1.30 | 30.22 ± 1.93# |
* different from the tumour control group, p 0.05;
# different from the CY group, #p 0.05;
CY: cyclophosphamide.
ASMq: abnormal Savda Munziq traditional Uyghur medicine.